Table 3.

Relations between variables associated with an increased risk of fracture and HR-pQCT or DXA (Spearman correlations)

AgeDialysis DurationBMIGenderFracturePrevious KTXPTHOsteocalcinCTXAP
HR-pQCT tibia
    Dtot−0.19a−0.36b0.21−0.19−0.34b−0.29a−0.20−0.050.05−0.36b
    Dcort−0.51c−0.14−0.07−0.03−0.37c−0.11−0.070.180.13−0.34b
    CtTh−0.30b−0.230.22−0.26a−0.42c−0.24a−0.060.110.10−0.30a
    Dtrab−0.02−0.44c0.19−0.24a−0.23a−0.25a−0.26a−0.150.03−0.26a
    BV/TV−0.03−0.44c0.14−0.20−0.23a−0.26a−0.24a−0.100.09−0.25a
    TbN−0.070.24a0.30b−0.33b−0.23a−0.21−0.14−0.100.03−0.29a
    TbTh0.02−0.33b−0.24a0.15−0.05−0.16−0.170.010.100.01
    Tb1/NSD0.060.27a−0.32b0.35b0.25a0.200.180.13−0.010.36b
HR-pQCT radius
    Dtot−0.21a−0.49c0.17−0.07−0.21−0.41c−0.160.040.10−0.27a
    Dcort−0.36b−0.36b0.100.08−0.24a−0.36b−0.060.190.16−0.29a
    CtTh−0.25b−0.38b0.30a−0.08−0.30a−0.38c−0.050.180.19−0.25a
    Dtrab−0.11−0.43c0.02−0.35b−0.22−0.29a−0.27a−0.19−0.08−0.22
    BV/TV−0.11−0.45c0.01−0.34b−0.21−0.30a−0.26−0.18−0.04−0.21
    TbN−0.06−0.220.08−0.37b−0.24a−0.28a−0.27a−0.16−0.16−0.22
    TbTh−0.10−0.39b−0.11−0.08−0.04−0.18−0.21−0.110.01−0.03
    Tb1/NSD0.060.27a−0.150.30a0.200.34b0.33b0.180.120.31b
DXA
    femoral neck aBMD−0.21−0.180.39c−0.14−0.32b0.03−0.230.150.09−0.20
    lumbar spine aBMD0.21−0.25a0.12−0.23−0.12−0.16−0.37b−0.060.03−0.21
    distal radius aBMD−0.19−0.56c0.35b−0.49c−0.49c−0.37b−0.030.260.36b−0.24
  • HRpQCT, high-resolution peripheral quantitative computed tomography; DXA, dual-energy x-ray absorptiometry; BMI, body mass index; KTX, kidney transplantation; PTH, parathyroid hormone; CTX, c-telopeptide crosslinks; AP, alkaline phosphatase; Dtot, total density; Dcort, cortical density; CtTh, cortical thickness; Dtrab, trabecular thickness; BV/TV, trabecular bone volume; TbN, trabecular number; TbTh, trabecular thickness; Tb1/NSD, SD of 1/TbN; aBMD, areal bone mineral density.

  • a P < 0.05,

  • b P < 0.01,

  • c P < 0.001.